Fig. 5

The concentrations vs percentage Inhibition and IC₅₀ Curves (dose response) of a) (Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide and b) Acetazolamide by non-linear regression analysis using GraphPad Prism 5.0